newsfilter
← Latest News
PR Newswire·

PDL BioPharma Reaffirms Commitment To Shareholder Value Creation

PDL BioPharma, Inc. ("PDL" or the "Company") (Nasdaq: PDLI) today issued the following statement in response to Engine Capital LP's ("Engine")...